J&J finally decides to dismantle its diversified business mo...

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operation

Three strategies for managing loss of exclusivity successful...

Prescient Announces Recent Appointments to its Senior Team

Prescient hires two new senior members to Senior Team

Prescient Intelligence & Insight Announces Recent Appointmen...

Prescient Intelligence & Insight hires 3 senior leads

Merck to spin old drugs into ‘NewCo’ focused on generics, wo...

GSK must continue to improve R&D, says CEO Walmsley

It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline, and at the time was seen as the protégé of her predecessor Sir Andrew Witty.